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DObjective: We sought to identify determinants of clinical and functional outcome after myocardial revasculari-
zation and associated undersized annuloplasty in patients with intermediate-degree ischemic mitral regurgitation.
Methods: Fifty-seven patients with 2þor 3þ ischemic mitral regurgitation underwent coronary bypass surgery
and implantation of undersized semirigid or flexible complete ring or autologous pericardial band and were fol-
lowed up to 8.6 years.
Results: Operative mortality was 5%. Baseline left ventricular end-systolic volume index, the strongest multi-
variable predictor of early postoperative outcome, was correlated with end-systolic volume index (P< .001,
R2 ¼ 0.67) and ejection fraction (P< .001, R2 ¼ 0.40) after repair. More compromised ejection fraction and
end-systolic volume index predicted comparatively greater early functional improvement but higher residual
postoperative end-systolic volume index (P< .01). Cox multivariable analysis identified wall motion as the
best baseline predictor of late death and heart failure and regional inferoposterior wall motion as the strongest
predictor of recurrent mitral regurgitation (P .01). More rigid annuloplasty carried a higher probability of func-
tional recovery in terms of ejection fraction, wall motion, and the occurrence and earlier timing of left ventricular
reverse remodeling, expressed by different degrees of end-systolic volume index reduction (P< .001, hazard
ratio>6).
Conclusions: Combination of undersized mitral annuloplasty and coronary revascularization presents low
operative mortality and determines left ventricular unloading in patients with intermediate-degree ischemic mitral
regurgitation. Global and regional wall motion are powerful predictors of late outcome. Stiffer mitral annular
repair promotes functional recovery and predicts higher probability and earlier timing of reverse remodeling.
(J Thorac Cardiovasc Surg 2010;139:1529-38)Ischemic mitral regurgitation (MR) is a common determi-
nant of adverse prognosis in ischemic heart disease. Surgi-
cal correction of severe MR at the time of coronary artery
bypass grafting (CABG) is recommended, but optimal
management of intermediate-degree MR is more contro-
versial.1-5 Furthermore, combined mitral surgery may be
judged unwise for patients with comorbidities.6,7 Although
previous experience also supports repair for patients with
mild-to-moderate ischemic MR,8 data from randomized
trials are scarce,9 and benefits related to long-term outcome
remain to be ascertained.9,10 Controversy also exists re-
garding the variability of prosthetic devices and surgical
techniques.11e Department of Cardiovascular Sciences, University of Milan, Milan, Italy.
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The Journal of Thoracic and CarMATERIALS AND METHODS
Patients
Cases of all patients with 2þor 3þ ischemic MR who underwent under-
sized mitral annuloplasty and associated CABG between 2000 and 2007 at
our institution were retrospectively analyzed. The study population com-
prised a consecutive series of 57 patients. All patients had previous myocar-
dial infarction at least 16 days before surgery.10 Exclusion criteria were as
follows: emergency operation, residual 2þMR before discharge, and asso-
ciated cardiac procedures other than tricuspid valve repair (n¼ 4). Preoper-
ative characteristics are summarized in Table 1. Unless otherwise specified,
definitions refer to EuroSCORE criteria.
Surgery and Perioperative Course
Operations were performed through median sternotomy with mildly hy-
pothermic cardiopulmonary bypass (32C core temperature) and intermit-
tent antegrade-retrograde cold blood cardioplegia with controlled
reperfusion. The mitral valve was accessed through a conventional left at-
riotomy (n ¼ 46) or transseptally (n ¼ 11). Analogously with other re-
ports,12 the annulus was reduced by 2 sizes with the implantation of
a prosthetic complete semirigid ring (n ¼ 10, Carpentier-Edwards Physio;
Edwards Lifesciences, Irvine, Calif) or complete flexible ring (n ¼ 24,
St Jude Tailor; St Jude Medical, Inc, St Paul, Minn) or with a glutaralde-
hyde-fixed autologous posterior pericardial band calibrated on a Carpent-
ier-Edwards ring sizer (n ¼ 23). There was a progressive shift toward
a more rigid repair, which reflected a general attitude of our group ratherdiovascular Surgery c Volume 139, Number 6 1529
TABLE 1. Preoperative characteristics (n ¼ 57)
Age (y)
Mean  SD 69.1  7.6
Range 53–82
Sex (male/female ratio) 39:18
Chronic pulmonary disease (no.) 24 (42.1%)
Extracardiac arteriopathy (no.) 32 (56.1%)
Neurologic dysfunction (no.) 8 (14.0%)
Creatinine>180 mmol/L (no.) 14 (24.5%)
Previous cardiac surgery (no.) 4 (7.0%)
Urgent operation (no.) 10 (17.5%)
Critical preoperative state (no.) 12 (21.1%)
Intravenous nitrates (no.) 17 (29.9%)
Left bundle branch block (no.) 14 (24.5%)
New York Heart Association functional class
Mean  SD 2.9  0.6
II (no.) 10 (17.5%)
III (no.) 39 (68.4%)
IV (no.) 8 (14.0%)
Infarction–surgery interval (mo, mean  SD) 64.0  95.4
Inferoposterior/anterior infarction ratio
No. 44:13
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
ICU ¼ intensive care unit
LV ¼ left ventricular
LVEF ¼ left ventricular ejection fraction
LVESVI ¼ left ventricular end-systolic volume
index
MR ¼ mitral regurgitation
WMSI ¼ wall motion score index
WMSInf ¼ regional inferior wall motion score
index
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Dthan specific preferences of different operating surgeons. All patients re-
ceived an internal thoracic artery graft to the left anterior descending branch.
Operative deaths include hospital and 30-day mortalities. High-dose ino-
tropic support refers to epinephrine infusion rates at least 0.1mg $ kg1 $min1.
A complicated postoperative course was defined as the placement of
intra-aortic balloon pump counterpulsation, high-dose inotropic support,
or intensive care unit (ICU) stay at least 5 days.
% 77.2%:22.8%
Pulmonary arterial pressure (mm Hg, mean  SD) 44  10
Additive EuroSCORE (mean  SD) 9  4Echocardiographic Evaluation
Left ventricular (LV) volumes and LV ejection fraction (LVEF) were
assessed by the biplane Simpson method. Wall motion score index
(WMSI) was calculated according to a 16-segment model and a 3-grade
scale, referring to normokinesia, hypokinesia, and akinesia. Four of 912
total segments, coded as grade 4 and indicating localized dyskinesia in
3 patients, were entered as grade 3. MR was graded as 0 (absent), 1þ
(mild), 2þ (moderate), 3þ (moderately severe), or 4þ (severe) on the basis
of color Doppler extent and spatial distribution of the regurgitant jet
relative to left atrial area.
The following variables were analyzed as potential outcome predictors
both preoperatively and early postoperatively, after ICU discharge: LV
end-diastolic and end-systolic diameters and volumes (crude and indexed
to body surface area), left atrial anteroposterior and longitudinal diameters,
LVEF, WMSI, and MR degree. The following preoperative variables were
also analyzed: LV sphericity (expressed as end-diastolic major axis/minor
axis ratio), regional inferior WMSI (WMSInf, calculated as the mean wall
motion score of the 6 basal and midventricular posteroseptal, inferior, and
posterior segments), percentage of akinetic segments, coaptation depth of
the tethered leaflets,13 central versus eccentric regurgitant jet, degree of tri-
cuspid regurgitation, and systolic pulmonary arterial pressure. Postoperative
LVEF, WMSI, LV end-systolic volume index (LVESVI), and their respec-
tive variations, expressed as postoperative to preoperative ratios, were ana-
lyzed to depict functionally the early response to surgery, residual LV
dysfunction, and the occurrence of early reverse remodeling, defined as at
least 10% reduction in LVESVI.
Follow-up
Late data were obtained from clinical follow-up, telephone interviews, or
both. All survivors underwent echocardiography at least 6 months after the
operation. All-cause and cardiac-related deaths (including operative mortal-
ity), recurrent heart failure (New York Heart Association class 3), and re-
current MR (3þor 2þ) were analyzed as late adverse events. Functional
end points were as follows: sustained improved LVEF, WMSI, or LVESVI
(late/early postoperative ratio>1 for LVEF or<1 for WMSI and LVESVI);
a 5% or 10% LVEF increment from baseline; and late reverse remodeling,
defined as at least 10% LVESVI postoperative reduction or 15% or 20%
LVESVI reduction from baseline.1530 The Journal of Thoracic and Cardiovascular SurEarlydatawere 100% complete. Twopatients from remote areas couldnot
be traced, however, accounting for a 96.3% completeness of late follow-up.
Statistical Analysis
Continuous variables are expressed asmean SD unless otherwise spec-
ified. The 2-tailed t test was used to compare means. The c2 test or Fisher’s
exact test when appropriate and binary logistic regression were used for uni-
variable andmultivariable analyses of early outcome. Predictors with a trend
toward significance (P< .10) were entered into the multivariable analysis.
Receiver operating characteristic curves served to identify cutoff values of
significant predictors. The Cox proportional hazard model served to identify
predictors of late events with time, testing preoperative and early postoper-
ative covariates separately. Two blocks of 11 preoperative variables (age, in-
farction–surgery interval, LVEF, WMSI, WMSInf, percentage of akinesia,
LVESVI, coaptation depth, sphericity, annuloplasty technique, and ring
size) and 6 early postoperative variables (complicated course, LVEF, im-
proved LVEF, WMSI, LVESVI, and 10% LVESVI early reduction)
were entered as covariates. Annuloplasty technique was coded as 0 for peri-
cardial annuloplasty, 1 for flexible ring, and 2 for semirigid ring implantation
to create a mitral annular stiffening score. Relationships between 8 baseline
continuous variables (infarction–surgery interval, LVEF, WMSI, WMSInf,
percentage of akinesia, LVESVI, coaptation depth, and sphericity) and 6
early postoperative continuous variables (LVEF,WMSI, LVESVI, and their
respective improvements expressed as postoperative/preoperative ratios)
were outlined with linear regression analysis. Probabilities of late events
and differences in probability estimates were calculated with the Kaplan–
Meier method and the log-rank test. SPSS software for Windows (version
13.0; SPSS, Inc, Chicago, Ill) was used for computations.RESULTS
Early Outcome
Three operative deaths (5.3%) occurred 5, 11, and 23
days after the operation. The causes of death were asgery c June 2010
TABLE 2. Perioperative variation of functional variables
Preoperative Postoperative P value
LV ejection fraction
(%, mean  SD)
36.21  9.48 37.07  8.38 .46
Wall motion score index
(mean  SD)
1.94  0.33 1.83  0.36 .01
Left atrial diameter (mm, mean  SD)
Anteroposterior 45.68  5.46 43.09  4.12 <.001
Longitudinal 58.07  6.59 54.00  5.27 <.001
LV diameter (mm, mean  SD)
End-diastolic 59.89  5.92 56.51  5.35 <.001
End-systolic 46.11  7.82 42.53  7.89 <.001
LV volume (mL, mean  SD)
End-diastolic 144.39  40.45 121.67  36.34 <.001
End-systolic 91.40  33.59 77.00  29.80 <.001
LV diameter index (mm/m2, mean  SD)
End-diastolic 33.95  3.84 32.05  3.66 <.001
End-systolic 26.12  4.57 24.12  4.74 <.001
LV volume index (mL/m2, mean  SD)
End-diastolic 81.37  21.51 68.75  20.53 <.001
End-systolic 51.59  18.74 43.47  16.77 <.001
Mitral regurgitation degree
(mean  SD)
2.47  0.60 0.56  0.50 <.001
LV, Left ventricular.
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fractory heart failure, and respiratory insufficiency. Al-
though purely indicative (in view of the different
techniques and sizers), ring size after repair was 26.8 
1.0 (range, 24-30). Myocardial revascularization was com-
plete (2.5  0.9 grafts/patient). Cardiopulmonary bypass
and aortic crossclamp times were 158  36 and 106  25
minutes, respectively. ICU stay averaged 6  5 days,
whereas intra-aortic balloon pump, high-dose inotropic sup-
port, and ICU stay of at least 5 days were required in 5, 31,
and 32 cases, respectively, accounting for a fully uncompli-
cated postoperative course in only 13 of 57 cases (22.8%).
Multivariable analysis failed to identify independent predic-
tors of early death. Similarly, no preoperative variable could
anticipate a prolonged ICU stay, but a higher LVESVI did
predict a complicated postoperative course as a cumulative
event (P ¼ .009).
MR degree (P<.001), WMSI (P¼ .01), and all atrial and
ventricular end-diastolic and end-systolic dimensions
(P < .001) improved significantly early after repair, but
LVEF did not (P¼ .46; Table 2), whereas several functional
variables independently predicted the perioperative outcome
(Table 3). Older infarcts determined a higher probability of
improved WMSI or LVESVI but also of a lower LVEF.
More specifically, surgery at least 24 months after myocar-
dial infarction anticipated a higher probability of a LVEF
of 35% or less after the operation (P ¼ .001, area under
the curve 0.75; sensitivity 72.4%, specificity 71.4%), but
a lower baseline LVEF showed a higher probability of im-
provement. Notably, all patients with baseline LVEF lower
than 30% had improvement, and a LVEF of 36% or less
discriminated patients more likely to have improvement
(P< .001, area under the curve 0.80, sensitivity 77.8%,
specificity 56.7%). Baseline LVESVI showed the highest
number of significant correlations with early outcome vari-
ables. In particular, a higher LVESVI predicted worse post-
operative LVEF and LVESVI but also a higher probability
of early LVESVI reduction; that is, of early LV reverse
remodeling. LVESVI of at least 54 mL/m2 predicted an early
postoperative LVESVI of at least 45 ml/m2 (P< .001, area
under the curve 0.89, sensitivity 87.5%, specificity 84.8%).
The strongest baseline predictors of postoperative
LVESVI, LVEF, and LVEF variation are illustrated in
Figure 1.
Late Results
Predictors of late events at Cox regression analysis are
specified in Table 4. At a mean follow-up of 43 29 months
(median, 40 months; interquartile range, 19–63 months; lon-
gest observation, 103 months), 12 late deaths were recorded.
Nine (75%) were cardiac related. Remaining causes of death
were stroke and end-stage lower extremity vascular disease
in 2 patients and 1 patient, respectively. Thus the cause of
death was always a major cardiovascular event. CardiacThe Journal of Thoracic and Cardeaths were related to end-stage heart failure in 5 instances
and sudden cardiac death or recurrent myocardial infarction
in 2 cases each. The survival curve (Figure 2, A) showed an
early 6-month higher-risk phase, an intermediate lower-risk
interval, and a late, more rapidly declining phase more evi-
dent after 4 to 5 years. Probabilities of survival (SE) were
90.8% 3.9%, 89.0% 4.2%, 86.5% 4.8%, 65.9%
9.0%, and 50.5% 10.4%, respectively, at 6 months and 1,
3, 5, and 7 years after surgery. Curves for all-cause and car-
diac-related mortalities were similar. Baseline and early
postoperative WMSI were the sole predictors of late all-
cause and cardiac-related mortalities at Cox multivariable
analysis, with a 0.1 increment determining a nearly 25%
higher probability of late death (P ¼ .01; Figure 2, B). The
predictive strengths of preoperative global and regional
WMSI values were confirmed by Kaplan–Meier analysis
(P ¼ .02 for WMSI 2, P ¼ .003 for WMSInf 2.2). The
latter also suggested different probabilities of late survival
in relation to preoperative sphericity of 1.3 or less (P ¼
.01) and early postoperative LVESVI of at least 45 mL/m2
(P¼ .009), but these trends were not confirmed by multivar-
iable analysis.
Heart failure, 3þMR, and 2þMR recurred in 9 patients
(17.3%), 5 (9.6%), and 19 (36.5%), respectively (Figure 2,
C–E). Probabilities of freedom from heart failure and recur-
rent MR at least 2þamong operative survivors (SE) were
98.1%  1.9%, 96.1%  2.7%, 91.0%  4.3%, 86.2%
 6.2%, and 71.1%  11.0%, and 100%, 100%, 97.2%
 2.7%, 86.0%  7.9%, and 86.0%  7.9%, respectively
at 6 months and 1, 3, 5, and 7 years after repair. One patientdiovascular Surgery c Volume 139, Number 6 1531
TABLE 3. Multivariable predictors of early outcome
LVEF WMSI LVESVI
High-dose
inotropic
support IABP
Complicated
course 35% Improved 2 Improved 45mL/m2 50mL/m2 Improved
Reduced
10%
Intravenous nitrates
P — .033 — — — — — — — — —
Odds ratio — 12.00 — — — — — — — — —
95% CI — 1.23–117.25 — — — — — — — — —
Left bundle branch block
P — — — — — .020 .017 — — — —
Odds ratio — — — — — 5.68 0.13 — — — —
95% CI — — — — — 1.31–24.63 0.02–0.69 — — — —
AMI–surgery interval (mo)
P — — — .010 — — .046 — — .044 —
Odds ratio — — — 1.03 — — 1.01 — — 1.04 —
95% CI — — — 1.01–1.05 — — 1.00–1.03 — — 1.00–1.07 —
Anterior AMI
P — — — — — .016 — — — — —
Odds ratio — — — — — 7.86 — — — — —
95% CI — — — — — 1.48–41.79 — — — — —
LVEF (%)
P .04 — — — <.001 — — — — — —
Odds ratio 0.94 — — — 0.75 — — — — — —
95% CI 0.88–1.00 — — — 0.64–0.89 — — — — — —
WMSI 2
P — — — — — — — — .039 — —
Odds ratio — — — — — — — — 10.64 — —
95% CI — — — — — — — — 1.13–100.39 — —
WMSI, 6 inferior segments 2.2
P — — — — — .021 — — — — —
Odds ratio — — — — — 5.89 — — — — —
95% CI — — — — — 1.30–26.71 — — — — —
Akinetic segments 25%
P — — — — — — .004 — — — —
Odds ratio — — — — — — 8.67 — — — —
95% CI — — — — — — 1.99–37.72 — — — —
LVESVI
P — — .009 .010 .050 — — <.001 .008 — .009
Odds ratio — — 1.06 1.07 0.94 — — 1.14 1.10 — 1.05
95% CI — — 1.01–1.11 1.02–1.12 0.89–1.00 — — 1.06–1.22 1.02–1.18 — 1.01–1.09
IABP, Intra-aortic balloon pump; LVEF, left ventricular ejection fraction; WMSI, wall motion score index; LVESVI, left ventricular end-systolic volume index; CI, confidence
interval; AMI, acute myocardial infarction.
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prosthetic valve replacement. Preoperative WMSI and early
postoperative LVESVI predicted adverse events at multivar-
iable analysis. WMSI was the strongest predictor of recur-
rent heart failure (P ¼ .01). No preoperative variable
reached statistical significance with respect to recurrent 3þ
MR, but WMSInf predicted late 2þMR (P¼ .009; Figure 2,
F). Conversely, early postoperative LVESVI predicted late
heart failure (P ¼ .02) and 3þMR (P ¼ .02) and showed
a strong trend toward significance with respect to late 2þ
MR (P ¼ .06). At Kaplan–Meier analysis, the strongest in-
dicator of adverse events excluding death was a WMSInf1532 The Journal of Thoracic and Cardiovascular Surof 2.2 or greater, which predicted recurrent heart failure
(P ¼ .008) and 2þMR (P ¼ .001). Coaptation depth of at
least 1 cmwas also identified as a predictor of adverse events
(P ¼ .01 for heart failure, P ¼ .004 for 2þMR) but not at
multivariable analysis.
The analysis of stability and improvement of ventricular
function (LVEF, WMSI, and LVESVI) during follow-up
demonstrated how patients with worse baseline and early
postoperative LVEF or with a more dilated LV early after re-
pair showed a higher probability of further late improve-
ment. A poorer WMSI early after surgery, however,
predicted a lower probability of late improvement in termsgery c June 2010
FIGURE 1. Relationships depicting strongest predictors of early postoper-
ative left ventricular end-systolic volume index (LVESVI), left ventricular
ejection fraction (LVEF), and left ventricular ejection fraction variation.
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a complicated postoperative course determined a 4- to
5-fold probability of worsened late WMSI (P< .001) and
LVESVI (P¼ .03). Interestingly, the sole preoperative vari-
able other than baseline LVEF to predict stable or improved
late LVEF was sphericity (P ¼ .03).
Kaplan–Meier analysis outlined a relatively constant
probability of LV reverse remodeling with time, expressed
as LVESVI reduction of at least 20% from baseline, which
resulted in probability values of (SE) 1.9% 1.9%, 1.9%
 1.9%, 25.1%  6.6%, 43.4%  8.5%, and 54.0% 
10.0%, at 6 months and 1, 3, 5, and 7 years after repair
(Figure 3A). The probability of functional benefit was com-
paratively higher for patients with a preoperative LVESVI of
at least 50 mL/m2 (P ¼ .001; Figure 3, B). Similarly, multi-
variable analysis showed the predictability of late reverse re-
modeling by a higher baseline (P < .01) or early
postoperative LVESVI (P ¼ .047).The Journal of Thoracic and CarNotably, a more rigid mitral annular stabilization strongly
predicted the probability of stable or improved late LVEF,
WMSI, and LVESVI (P< .001) at multivariable analysis.
Most importantly, a stiffer annulus predicted late LVEF
improvement and the occurrence and earlier timing of LV
reverse remodeling (P  .001). Kaplan–Meier analysis
generated similar observations (P< .001; Figure 3, C).
DISCUSSION
Although CABG alone often results in improved LV
function and MR, the latter does not resolve in a wide pro-
portion of patients and predicts a poor prognosis.14,15 Fur-
thermore, mortalities in excess of 10% have been
reported after ischemic MR repair at the time of CABG,
and combined operations are less commonly performed
in higher-risk patients if regurgitation is not severe.3-7
Although previous reports support the benefits of repair
also in mild-to-moderate ischemic MR, the optimal treat-
ment of intermediate-degree ischemicMR remains a debated
issue, and indications vary widely.8-10
Death
Operative mortality was 5%, similar to previous reports
and lower than estimated with the EuroSCORE. All late
deaths were caused by cardiac or vascular events, and heart
failure was responsible for half of the cardiac-related mortal-
ity. The prevalence and modality of deaths reflect the sever-
ity of atherosclerotic disease and the unfavorable prognostic
impact of underlying ventricular dysfunction, stressing the
role of medical therapy for heart failure, resynchronization,
and implantable defibrillators.
Baseline and early postoperative WMSI represented the
only independent risk factors for late death. Unlike the roles
of LVEF, LVESVI, and LV diameters,6,12,16,17 the prognos-
tic role of WMSI in patients with LV dysfunction has not
been emphasized. Survival analysis outlined how patients
with a preoperative WMSI of at least 2 showed a more evi-
dent late phase of increased risk of death, which was not
correlated with MR recurrence. Ongoing trials may suggest
adjunct procedures for patients with more severe dilatation
and advanced cardiomyopathy.18,19
Adverse Events
Prolonged ICU stay, intra-aortic balloon pump, higher-
dose catecholamine support was required in more than
75% of the cases. This finding reflects more advanced base-
line LV remodeling, indicated by a higher LVESVI. Con-
versely, LVEF was a weaker predictor of high-dose
inotropic support.
Overall, the probabilities of recurrent heart failure and 3þ
MR at late follow-up were low and similar to results reported
by others with an equal degree of annular downsizing.12
WMSI was the only independent preoperative predictor of
recurrent heart failure. Similarly, recurrent 2 þ MR wasdiovascular Surgery c Volume 139, Number 6 1533
TABLE 4. Multivariable predictors of late outcome
Adverse event Left ventricular function and reverse remodeling*
Death MR LVEF WMSI LVESI
All cause
Cardiac
related
Heart
failure 3þ 2þ Improved
Increase
5% from
baseline
Increase
10% from
baseline Improved Improved
Reduction
10%
Reduction
15% from
baseline
Reduction
20% from
baseline
LVEF, preoperative (%)
P — — — — — .038 — — — — — — —
OR — — — — — 0.95 — — — — — — —
95% CI — — — — — 0.90–1.00 — — — — — — —
WMSI, preoperativey
P .011 .026 .012 — — — — .007 — — — — —
OR 1.23 1.23 1.35 — — — — 1.51 — — — — —
95% CI 1.05–1.45 1.02–1.48 1.07–1.71 — — — — 1.22–2.04 — — — — —
WMSI of 6 inferior segments, preoperativey
P — — — — .009 — — — — — — — —
OR — — — — 1.17 — — — — — — — —
95% CI — — — — 1.04–1.32 — — — — — — — —
LVESVI, preoperative
P — — — — — — — — — — — .009 .007
OR — — — — — — — — — — — 1.03 1.04
95% CI — — — — — — — — — — — 1.01–1.06 1.01–1.06
Sphericity ratio, preoperativey
P — — — — — .032 — — — — — — —
OR — — — — — 1.43 — — — — — — —
95% CI — — — — — 1.03–1.99 — — — — — — —
Annuloplasty technique
P — — — — — <.001 <.001 <.001 <.001 <.001 .001 <.001 <.001
OR — — — — — 7.54 15.06 16.95 6.10 7.24 13.38 7.40 6.75
95% CI — — — — — 3.30–17.24 5.40–41.98 4.20–68.33 2.58–14.44 2.72–19.25 2.93–61.06 2.82–19.41 2.44–18.72
Complicated course
P — — — — — — — — <.001 .021 — — —
OR — — — — — — — — 0.18 0.23 — — —
95% CI — — — — — — — — 0.08–0.45 0.07–0.80 — — —
LVEF, early postoperative (%)
P — — — — — .007 — — — .047 — — —
OR — — — — — 0.92 — — — 0.92 — — —
95% CI — — — — — 0.86–0.98 — — — 0.86–0.98 — — —
WMSI, early postoperativey
P .023 .045 — — — .032 — — — .013 — — —
OR 1.16 1.16 — — — 0.84 — — — 0.75 — — —
95% CI 1.02–1.36 1.00–1.34 — — — 0.72–0.99 — — — 0.63–0.94 — — —
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DCarpredicted by a worse baseline WMSInf. The predictive role
of WMSInf may correlate with an increased posterior leaflet
angle, which has been identified as an accurate predictor of
adverse outcome after ischemic MR repair.20 Furthermore,
LVESVI early after surgery predicted all late adverse events
at multivariable analysis, but baseline LVEF and LVESVI
did not reach statistical significance. Only 1 patient under-
went reoperation for recurrentMR, and no preoperative vari-
able was able to predict recurrent 3þMR. Unlike previous
reports, coaptation depth could not independently predict
MR repair failure,13 but a higher WMSInf was correlated
with a higher incidence of late 2þMR, which may suggest
a potential rationale for chord-sparing mitral valve replace-
ment. In fact, this is now the source of a prospective random-
ized multicenter trial funded by the National Institutes of
Health (ClinicalTrials.gov Identifier NCT00807040).
Early Postoperative LV Function
Patients with more compromised preoperative LVESVI,
WMSI, or LVEF, or with an older infarction showed a higher
probability of early reverse remodeling but a parallel inci-
dence of residual higher LVESVI early after the operation,
which reflects the severity of the underlying cardiomyopa-
thy. A higher potential for early functional improvement
may partially explain the lower than predicted operative
mortality. These observations are in contrast with previous
reports indicating that patients with more dilated ventricles
are less likely to have responses.12 In our series, however,
baseline LVESVI was lower, possibly because MR was
less severe and patients with 4þMR were excluded.
Interestingly, LVEF did not vary significantly early after
repair, but our analysis suggests that LVEF improvement
might be expected to occur more often in patients with
higher LVESVI before surgery. LVEF of 36% or less
emerged as a cutoff to discriminate patients more likely to
show an early LVEF improvement. More importantly, all
patients with baseline LVEF less than 30% had improve-
ment. In this context, LVEF increase of at least 5% has
been previously used to define functional recovery in pa-
tients with ventricular dysfunction undergoing CABG with
or without associated MR repair.6 We also tested for
a LVEF increase of at least 10%, however, because a lower
cutoff may underestimate the potential benefits of a com-
bined operation, which predicts a comparatively greater
LVESVI reduction than with isolated CABG despite similar
baseline and early postoperative LVEF values.
Conversely, LVESVI is considered the preferred method
to assess LV remodeling and function, especially in the pres-
ence of MR.16 Baseline LVESVI was the strongest predictor
of early postoperative LVEF and LVESVI and their respec-
tive variations, whereas a worse postoperative WMSI could
be predicted in patients with left bundle branch block or pre-
vious anterior infarction. The possibility to predict an unfa-
vorable residual LVESVI, at least 40 or 50 mL/m2,diovascular Surgery c Volume 139, Number 6 1535
FIGURE 2. Kaplan–Meier plots illustrating survival (A and B) and freedom from adverse events (C–F).WMSI, wall motion score index;WMSInf, regional
inferior wall motion score index; MR, mitral regurgitation.
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Drepresents an important issue, with the underlying rationale
to indicate associated LV restoration procedures. In our ex-
perience, a baseline LVESVI of at least 54 mL/m2 predicted
an early postoperative LVESVI of at least 45 mL/m2. This
observation is similar to previous reports related to LV diam-
eters and suggests that selected patients may be further eval-
uated with magnetic resonance imaging to define LV
volumes more accurately before an associated ventricular
surgical approach in the presence of a baseline LVESVI of
at least 55 or 60 mL/m2. In this context, the minority of pa-
tients with previous anterior myocardial infarction in our se-
ries was confined to earlier years, before 2002, reflecting the
increasing incidence of ventricular reconstructive proce-
dures in cardiac surgical practice. The role of associated ven-
tricular restoration will further be clarified by randomized
trials.17 Conversely, no ventricular procedure is currently
adopted in case of previous inferior infarction, and ap-
proaches under investigation, both clinically and experimen-
tally, are aimed more at restoration of mitral leaflet
coaptation than at ventricular volume reduction.19,211536 The Journal of Thoracic and Cardiovascular SurMitral Annular Stiffening and Late Reverse
Remodeling
Baseline predictors of early and late functional recovery
were similar, whereas the predictive trends of early postop-
erative variables were less clear-cut. Overall, late LVEF and
LVESVI were more frequently improved in cases of more
advanced ventricular disease in terms of LVEF, WMSI,
and LVESVI. A more spherical ventricle, however, had
less potential for late LVEF improvement. This outlines
the importance not only of LV size and contractility but
also of ventricular geometry, because undersized mitral an-
nuloplasty restores a more physiologic sphericity.22 Interest-
ingly, sphericity has been recently reported to independently
predict early functional recovery after valve replacement for
aortic stenosis.23 Conversely, the prognostic role of recur-
rent MR remains less defined with respect to the vicious cy-
cle among MR itself, volume overload, and progressive
remodeling.
Finally, the rigidity of annular restriction predicted late
functional recovery. Undersized annuloplasty has beengery c June 2010
FIGURE 3. Kaplan–Meier plots illustrating occurrence of left ventricular
(LV) reverse remodeling (A), expressed as late left ventricular end-systolic
volume index (LVESVI) reduction of at least 20% from baseline, and effects
of preoperative left ventricular end-systolic volume index (B) and different
annuloplasty techniques (C).
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Dexperimentally correlated with reduced myocardial perfor-
mance in the basal segments,24 but this may be affected by
the different tractions determined by suture techniques
used in experimental models, especially in the anterobasal
region. Basal contractility is substantially absent after infero-
posterior infarction, however, which is the most common
cause of ischemic MR. In our experience, a stiffer repair de-
termined higher probabilities of improved late LVEF and
WMSI and, most importantly, of reverse remodeling, as pre-
viously suggested.11 Survival analysis also outlined an ear-
lier timing of reverse remodeling. Previous observations
outlined how the implantation of a complete rigid ring deter-
mines a more pronounced reduction of the anteroposterior
mitral diameter and consequently a greater reduction of ven-
tricular wall stress.11 We did not implant a fully rigid ring,
such as the Carpentier Classic, and a recent study did not re-
port differences between Carpentier Classic and PhysioThe Journal of Thoracic and Carrings.17 MR recurrence with the Physio ring was lower
than reported by others, however, in a recent analysis of
100 consecutive patients.12 True comparisons between dif-
ferent devices are not possible because apparently equal
sizes, as declared by manufacturers, correspond to different
valve areas and diameters and yield different annular under-
sizing and potential for leaflet coaptation. For example,
a size 24 Physio ring is similar to a size 26 Classic ring,
and the latter has a comparatively shorter anteroposterior di-
ameter. Thus ultimate ring size after repair (26.8 in our pa-
tients) may determine different results and is of little
significance per se. We were unable to outline a predictive
value of annular rigidity with respect to MR recurrence,
but this has been well elucidated previously and is likely
to be related to our small population, small number of ad-
verse events, and small number of patients with a stiffer
ring.25 On theoretic grounds, the substantial absence of det-
rimental effects on myocardial function related to a more
rigid annulus may allow us to expand indications for mitral
valve replacement to selected patients with ischemic MR,
provided that a chord-sparing technique is used.
Limitations
The major drawbacks are inherent in the retrospective
nature of the study and the small number of patients. In
addition, different annuloplasty techniques were not
homogeneously distributed during the study period, with
stiffer rings being progressively implanted in more recent
years and in fewer patients. The pattern of techniques may
have depended in part on different preferences of operating
surgeons. Finally, the stiffening score used for analysis was
arbitrarily defined and may not quantify stiffness from
a mathematic standpoint. Statistical significance was
reached with predictors entered as continuous nondichotom-
ized variables, when appropriate, however, and the Cox
analysis was repeated to test the appropriateness of the
arbitrary stiffness coding, entering different numerical
combinations of the score (namely, 1-2-3, 1-2-4, 1-3-4,
1-2-5, and 1-3-5) and obtaining the same P values with
only minor differences in the corresponding hazard ratios.
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